ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.

ConvaTec Group Plc

ConvaTec is a medical products and technologies company that develops, manufactures, and markets products for the management of chronic conditions, with a focus on advanced wound care, ostomy care, continence and critical care, and infusion care.

ConvaTec

Convatec Infusion Care

Convatec Ostomy Care

Convatec Nederland

Flexi-Seal™ Fecal Management System

Convatec Continence Care

Convatec Wound

Clínica ConvaCare

At Convatec, #ForeverCaring is our promise to patients & healthcare providers, as we deliver pioneering trusted medical solutions to improve the lives we touch. 

#ForeverConvatec

Convatec

Hidden health conditions are not always immediately obvious to others, but the more you understand about them, the more people feel seen. 

At Convatec we are on a journey to Forever caring, find out more here: https://lnkd.in/eUKmshiy 

#ForeverCaring #ForeverConvatec #HiddenHealthConditions

This week, colleagues at our largest UK manufacturing site in Deeside, north Wales were pleased to host a visit from the local Member of Parliament, the Rt Hon Mark Tami. During his visit, Mark met colleagues and was given a demonstration of our different products and solutions in advanced wound care, as well as a tour of our facilities including our textile line and new clean room.
 
Our CFO Jonny Mason and UK manufacturing site leader Adeel Mushtaq enjoyed hosting Mark, alongside other leaders in research and development and operations. Mark was also able to spend time with several of our apprentices and summer interns to hear more about how our teams are bringing to life our vision of pioneering trusted medical solutions to improve the lives we touch. 

#ForeverCaring #ForeverConvatec #WeAreConvatec #Deeside

Today, on World Humanitarian Day, we recognise the important role of humanitarian workers in delivering life-saving support and protection to those who need it most. 

In line with our forever caring promise, we also support humanitarian partners who serve vulnerable populations in our communities. This year we contributed to relief efforts around the catastrophic flooding in South Brazil, and the devastating earthquake in Japan. We also continued to support our charity partners working in Ukraine, with additional product donations bringing our total contribution to over $2 million.

In addition, we take this moment to thank our global charity partner, Partners In Health (PIH). Through our partnership, PIH has facilitated the training and equipping of hundreds of Community Health Workers (CHW), which by extension, have touched the lives of thousands of people. 

#WorldHumanitarianDay #ConvateCares #PIH 
#WeAreConvatec #ForeverCaring #ForeverConvatec

Hidden health conditions are more common than you may think, and many people don’t know much about them at all.
 
Find out more about how Convatec can support you here: https://lnkd.in/eUKmshiy
 
#ForeverCaring #ForeverConvatec #HiddenHealthConditions

Starting your treatment doesn’t have to stop you from doing the things you love. Re-define your diagnosis.
 
#ForeverCaring #ForeverConvatec

	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	1.70B -	1.73B 1.97%	1.65B 4.83%	1.69B 2.30%	1.76B 4.52%	1.83B 3.83%	1.83B 0.27%	1.89B 3.67%	2.04B 7.60%	2.07B 1.68%	2.14B 3.37%
cost of revenue	755.70M -	826.60M 9.38%	799.90M 3.23%	821M 2.64%	838.30M 2.11%	858.30M 2.39%	871.60M 1.55%	874.20M 0.30%	915.20M 4.69%	968.60M 5.83%	941.80M 2.77%
gross profit	945M -	907.60M 3.96%	850.50M 6.29%	867.30M 1.98%	926.30M 6.80%	973.80M 5.13%	955.60M 1.87%	1.02B 6.75%	1.12B 10.10%	1.10B 1.71%	1.20B 8.76%
selling and marketing expenses	374.70M -	396.80M 5.90%	346.70M 12.63%	357M 2.97%	377.50M 5.74%	418M 10.73%	457.20M 9.38%	462.60M 1.18%	539.70M 16.67%	575.90M 6.71%	612.50M 6.36%
general and administrative expenses	231.50M -	249.70M 7.86%	233.10M 6.65%	318.20M 36.51%	259.80M 18.35%	238.20M 8.31%	230.20M 3.36%	251.40M 9.21%	285.30M 13.48%	214.90M 24.68%	212.90M 0.93%
selling general and administrative expenses	606.20M -	646.50M 6.65%	579.80M 10.32%	675.20M 16.45%	637.30M 5.61%	656.20M 2.97%	687.40M 4.75%	714M 3.87%	825M 15.55%	790.80M 4.15%	825.40M 4.38%
research and development expenses	31.20M -	42.20M 35.26%	40.30M 4.50%	38.10M 5.46%	41.20M 8.14%	49.90M 21.12%	54.80M 9.82%	83.70M 52.74%	94.50M 12.90%	92M 2.65%	110M 19.57%
other expenses	1.10M -	-23.80M 2,263.64%	-37.10M 55.88%	-8.40M 77.36%	-500K 94.05%	-1.30M 160%	-4.40M 238.46%			-12M -	700K 105.83%
cost and expenses	1.39B -	1.52B 8.77%	1.42B 6.29%	1.53B 8.05%	1.52B 1.14%	1.56B 3.14%	1.75B 12.02%	1.68B 4.28%	1.83B 9.38%	1.85B 0.91%	1.88B 1.39%
operating expenses	637.40M -	688.70M 8.05%	620.10M 9.96%	713.30M 15.03%	678.50M 4.88%	706.10M 4.07%	880.80M 24.74%	803.20M 8.81%	919.50M 14.48%	882.80M 3.99%	935.40M 5.96%
interest expense	261.90M -	294.90M 12.60%	303.60M 2.95%	271.40M 10.61%	58.40M 78.48%	65.20M 11.64%	73.60M 12.88%	44.10M 40.08%	44.30M 0.45%	64.70M 46.05%	73.30M 13.29%
ebitda	497.90M -	387.40M 22.19%	374.40M 3.36%	327.40M 12.55%	399.20M 21.93%	456.40M 14.33%	391.40M 14.24%	390.70M 0.18%	405.70M 3.84%	417.60M 2.93%	482.20M 15.47%
operating income	307.60M -	218.90M 28.84%	230.40M 5.25%	154M 33.16%	247.80M 60.91%	267.70M 8.03%	214.40M 19.91%	224.90M 4.90%	203.60M 9.47%	207.30M 1.82%	262.70M 26.72%
depreciation and amortization	189.20M -	192.30M 1.64%	181.10M 5.82%	181.80M 0.39%	179.40M 1.32%	190M 5.91%	177M 6.84%	165.80M 6.33%	202.10M 21.89%	210.30M 4.06%	214.80M 2.14%
total other income expenses net	-260.80M -	-318.70M 22.20%	-340.70M 6.90%	-281.40M 17.41%	-83.80M 70.22%	-66.50M 20.64%	-195.50M 193.98%	-50.20M 74.32%	-52.30M 4.18%	-125.40M 139.77%	-95.30M 24.00%
income before tax	46.80M -	-99.80M 313.25%	-110.30M 10.52%	-125.80M 14.05%	164M 230.37%	201.20M 22.68%	18.90M 90.61%	174.70M 824.34%	151.30M 13.39%	81.90M 45.87%	167.40M 104.40%
income tax expense	31.60M -	27.40M 13.29%	-16.90M 161.68%	77M 555.62%	5.50M 92.86%	-20.40M 470.91%	9.10M 144.61%	62.20M 583.52%	33.70M 45.82%	19M 43.62%	37.10M 95.26%
net income	15.20M -	-127.20M 936.84%	-93.40M 26.57%	-202.80M 117.13%	158.40M 178.11%	221.60M 39.90%	9.80M 95.58%	112.50M 1,047.96%	117.60M 4.53%	62.90M 46.51%	130.30M 107.15%
weighted average shs out	1.95B -	1.95B 0%	1.95B 0%	1.38B 29.47%	1.95B 41.75%	1.96B 0.26%	1.97B 0.76%	1.99B 1.04%	2.01B 0.87%	2.01B 0%	2.04B 1.48%
weighted average shs out dil	1.95B -	1.95B 0%	1.95B 0%	1.38B 29.47%	1.95B 41.96%	1.96B 0.21%	1.98B 0.92%	2.01B 1.54%	2.03B 0.98%	2.03B 0%	2.05B 1.30%
eps	0.01 -	-0.07 935.90%	-0.05 26.53%	-0.15 213.15%	0.08 153.33%	0.11 37.50%	0.01 95.45%	0.06 1,030%	0.06 4.42%	0.03 47.46%	0.06 106.45%
epsdiluted	0.01 -	-0.07 935.90%	-0.05 26.53%	-0.15 213.15%	0.08 153.33%	0.11 37.50%	0.01 95.45%	0.06 1,020.00%	0.06 3.57%	0.03 46.55%	0.06 103.23%

COM:CONVATECGROUP

ConvaTec

Last Close

233.00

21/11 16:35

Market Cap

49.54M

Beta: -

Volume Today

4.48M

Avg: -

Preview